SEC Form 4 · accession 0001209191-18-040492
AKCEA THERAPEUTICS, INC. · AKCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeff Marc Goldberg
Officer — Chief Operating Officer
Period of report
Jul 1, 2018
Accepted (ET)
Jul 2, 2018 · 7:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001662524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2018 | J | 1,398 | $14.773 | A | 2,387 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Although not required, the Reporting Person is voluntarily reporting the acquisition of 1,398 shares on July 1, 2018 pursuant to the Issuer's Employee Stock Purchase Plan.